SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-050215
Filing Date
2020-09-11
Accepted
2020-09-11 19:59:07
Documents
1
Period of Report
2020-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12862
  Complete submission text file 0001209191-20-050215.txt   14365
Mailing Address C/O BIOTRANSPLANT INC 196 BOSTON AVE SUITE 2800 MEDFORD MA 02155
Business Address
PERRY MICHAEL S (Reporting) CIK: 0001250379 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39059 | Film No.: 201171993

Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Issuer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences